Breast Cancer News and Research

Researchers untangle mysteries of 'evil' protein in ER-positive breast cancer

Breast cancer is one of the most common cancers in the United States, striking 1 out of 8 women. About 80 percent of all breast cancers are estrogen receptor-positive, in which cancer growth is fueled by estrogen.

Protein involved in milk production appears to stimulate growth and spread of breast cancer

VCU Massey Cancer Center researchers have identified a protein involved in milk production that stimulates the growth and spread of breast cancer and could ultimately serve as a target for novel therapies to treat breast cancer.

Increasing number of women learn about breast cancer diagnosis over the telephone

A new study from the University of Missouri School of Medicine reveals an increasing number of women are learning about their breast cancer diagnosis over the phone.

Acute changes in extracellular matrix can trigger rapid change in cell’s metabolism

UCLA researchers have found that the extracellular matrix, the dense network of proteins and carbohydrates that surround a cell, can influence how cells move within the body by regulating their sugar consumption.

Study reinvestigates benefit of biomarker tests in certain breast cancer patients

The German Institute for Quality and Efficiency in Health Care reinvestigated the benefit of biomarker tests to support the decision for or against adjuvant systemic chemotherapy in certain breast cancer patients, that is, women with primary hormone receptor-positive, HER2/neu-negative breast cancer and 0 to 3 affected lymph nodes.

Breast cancer cases among men who were at ground zero on 9/11

The after effects of the terror attacks on 11th September 2001 in the United States are still appearing. Around 15 men who were present near the Ground Zero on the fateful day have been diagnosed with rare forms of male breast cancer. Male breast cancer makes up for less than 1 percent of all breast cancers. 

This new data emerges from a client list of a law firm that is specially looking into health cases of those in and around the region on 9/11. There could be many more men who are outside of this data base say experts. Two of the men – Jeff Flynn (65 years old) and John Mormando (51 years old) who were near the zone were initially diagnosed with the cancer and are being treated for it. Both men say that there is no history of breast cancers in their family and they were exposed to toxins on the day.

Flynn was an account manager for a data-storage company Dell EMC and was assigned to Goldman Sachs on Maiden Lane on the fateful day. He was around the region for months after the attack helping Goldman and other financial services firms to set up again.

After a decade, in 2011, he first noticed an abnormality in one of his nipples and was then diagnosed with stage 3 breast cancer for which he underwent extensive operations. Soon the cancer returned as a stage 4 cancer. He was awarded compensation from the September 11th Victim Compensation Fund that helped him pay for his treatment. Mormando was a commodities broker working at the Mercantile Exchange until 2007. He is a triathlete now. Last year he noticed a lump on his chest and was diagnosed with the breast cancer.

Leon Silverstein (89 years old), an Army veteran, was diagnosed with breast cancer and had to be operated upon. As a result of the cancer both his breasts had to be removed in a double mastectomy. He used to live near Battery Park near the Ground Zero for 30 years.

Experts believe that apart from those killed during the attacks more people are emerging with long term after effects of the attack. There are over ten thousand individuals who were members of the first responders’ teams for rescue operations or were near the region when the attack took place.

These people have been diagnosed with various forms of cancers due to exposure to the toxins. Over 2000 individuals have ailments that can be attributed to the toxins on that day. The Chief of the fire Department of New York, for example, who was leading the first responder efforts died this June from cancer.

USC scientists develop new way to identify molecular markers of breast cancer tumors

A research team led by USC scientists has developed a new way to identify molecular markers of breast cancer tumors, a potentially life-saving breakthrough that could lead to better treatment for millions of women.

Researchers develop fully-automated medical image analysis program to detect breast tumors

Researchers from the University of Adelaide's Australian Institute for Machine Learning are developing a fully-automated medical image analysis program to detect breast tumors. The program uses a unique style to focus on the affected area.

AACI/CCAF annual meeting to highlight perspectives on future of cancer research and care

Perspectives on the future of cancer research and care, including the latest on CAR T-cell therapy, Big Data management, and international partnerships, will highlight the 2018 joint annual meeting of the Association of American Cancer Institutes and the Cancer Center Administrators Forum, September 30 – October 2, in Chicago.

Breakthrough fluorine discovery may impact how pharmaceutical companies develop new drugs

A groundbreaking discovery by chemists at The University of Texas at San Antonio will have a significant impact on how pharmaceutical companies develop new drug treatments.

New nuclear medicine imaging method could help diagnose widespread tumors

A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.

Study finds new clues to understand relapse in breast cancer

A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers from Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia.

All MSP participants with invasive breast cancer can undergo more sparing surgical treatment

Participants in the German mammography screening program (MSP) who have invasive breast cancer—including interval cancers—can on the whole undergo more sparing surgical treatment compared with non-participants.

Specific protein promotes processes associated with cancer aggressiveness, reports study

Japanese researchers have revealed for the first time that a specific protein plays a critical role in the development and metastasis of highly aggressive prostate and breast cancer cells.

Researchers discover potential new approach to block growth of HER2 positive breast cancer

Researchers at Mayo Clinic have identified an important new pathway by which HER2 positive breast cancers grow and have discovered that a dietary supplement called cyclocreatine may block the growth of HER2 positive breast cancer.

Study: Matcha green tea kills breast cancer stem cells

MATCHA, the Green Tea packed with antioxidants, is often hailed as containing properties which prevent disease.

Californians living longer with cancer — some longer than others

As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.

HKBU chemists discover metal-based inhibitor to treat triple-negative breast cancer

Chemists at Hong Kong Baptist University have discovered the use of a metal compound that inhibits the enzyme closely associated with triple-negative breast cancer, one of the most difficult forms of breast cancer to treat.

Wichita State University students create biometric tracking temporary tattoo

Wichita State University students Jared Goering, Ryan Becker and Spencer Steinert are working together to positively impact lives through wearable technology. Together they created a product called Cyfive and have been perfecting it for the past three years.

For nursing home patients, breast cancer surgery may do more harm than good

Surgery is a mainstay of breast cancer treatment, offering most women a good chance of cure.